Matsuoka Yoichiro, Fukamachi Katsumi, Uehara Norihisa, Tsuda Hiroyuki, Tsubura Airo
Second Department of Pathology, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan.
Cancer Sci. 2008 Feb;99(2):309-15. doi: 10.1111/j.1349-7006.2007.00689.x.
Refractoriness to carcinogen-induced increases in epithelial cell proliferation is a very important characteristic of parous mammary glands. We found that N-methyl-N-nitrosourea (MNU)-induced proliferative burst in the mammary ductal epithelium was blocked in parous glands but not in age-matched virgin (AMV) glands. The inhibition of the proliferative burst in MNU-treated parous mammary glands coincided with the upregulation of Mnt, a Myc-suppressor, and the formation of histone deacetylase 1/Mnt/Max complexes that unexpectedly contained c-Myc. These complexes formed on the promoters of Myc targets, such as ornithine decarboxylase, cyclin D2, and transforming growth factor beta1 genes, in quiescent fibroblasts, and were disassembled in serum-stimulated cells. These results suggest that the complexes also function as transcription repressors of the growth-related Myc targets in MNU-treated parous mammary glands. Using the chemical mammary carcinogenesis model of human c-Ha-ras transgenic (Tg) rats, we confirmed that parity protected the mammary glands at the postinitiation phase of tumorigenesis. Although the incidence of 7,12-dimethylbenz[alpha]anthracene-induced palpable tumors was reduced from 61.5% in the AMV Tg rats to 28.5% in the parous animals, the incidence of early neoplastic lesions in the parous rats was the same as that in the AMV rats. Restriction fragment length polymorphism analysis detected mutations in the human c-Ha-ras gene in most of the normal-appearing parous Tg glands, as well as in the virgin glands. We propose that accelerated formation of HDAC1/c-Myc/Mnt/Max complexes in response to carcinogen exposure results in down-regulation of growth-related genes, leading to the refractoriness of parous mammary glands at the postinitiation phase of carcinogenesis.
对致癌物诱导的上皮细胞增殖增加产生抗性是经产乳腺的一个非常重要的特征。我们发现,N-甲基-N-亚硝基脲(MNU)诱导的乳腺导管上皮细胞增殖爆发在经产乳腺中受到抑制,但在年龄匹配的未孕(AMV)乳腺中未受抑制。MNU处理的经产乳腺中增殖爆发的抑制与Myc抑制因子Mnt的上调以及组蛋白去乙酰化酶1/Mnt/Max复合物的形成相吻合,这些复合物意外地包含c-Myc。这些复合物在静止成纤维细胞中Myc靶基因(如鸟氨酸脱羧酶、细胞周期蛋白D2和转化生长因子β1基因)的启动子上形成,并在血清刺激的细胞中解体。这些结果表明,这些复合物在MNU处理的经产乳腺中也作为生长相关Myc靶基因的转录抑制因子发挥作用。利用人c-Ha-ras转基因(Tg)大鼠的化学性乳腺癌发生模型,我们证实经产状态在肿瘤发生的起始后阶段对乳腺起到保护作用。虽然7,12-二甲基苯并[a]蒽诱导的可触及肿瘤的发生率在AMV Tg大鼠中为61.5%,在经产动物中降至28.5%,但经产大鼠中早期肿瘤性病变的发生率与AMV大鼠相同。限制性片段长度多态性分析在大多数外观正常的经产Tg乳腺以及未孕乳腺中检测到了人c-Ha-ras基因的突变。我们提出,致癌物暴露后HDAC1/c-Myc/Mnt/Max复合物的加速形成导致生长相关基因的下调,从而使经产乳腺在致癌作用的起始后阶段产生抗性。